Natural Products Insider is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Omega-3 Pharmaceutical Approved in Norway


Omega-3 Pharmaceutical Approved in Norway

LYSAKER, Norway--OMACOR, a high-potency formulation of omega-3s (EPA and DHA), was approved in Norway for the treatment of post-infarct patients. It shows similar therapeutic effects to other cardiovascular therapies such as anti-hypertensives, statins and anti-platelets. The formulation has also been approved in the United Kingdom, Germany, France, Austria and Greece. OMACOR was developed from research by Pronova Biocare (

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.